Who Owns Palvella Therapeutics, Inc. (PVLA)?Hedge Fund & Institutional Holders

$124.50-12.10 (-8.86%)HealthcareNASDAQ

Institutional Holders

50

as of Q4 2025

Total Institutional Value

$9.340792005756138e+214T

% of Float Held

1.1113843920509473e+268%

QoQ Change in Holders

+15 / -4

Price History

$11.79$45.93$80.06$114.20$148.34Dec 24Aug 25Mar 26

PVLA — Biggest New Institutional Buyers This Quarter

FundActionShares AddedValue Added
JENNISON ASSOCIATES LLCNew Position+387K+$40.6M
FEDERATED HERMES, INC.New Position+368K+$38.0M
ALLIANCEBERNSTEIN L.P.New Position+269K+$28.0M
Artisan Partners Limited PartnershipNew Position+212K+$22.0M
EVENTIDE ASSET MANAGEMENT, LLCNew Position+102K+$10.6M
Clio Asset Management LLCNew Position+92K+$9.6M
NEXTBio Capital Management LPNew Position+83K+$8.7M
Siren, L.L.C.New Position+75K+$7.8M
Artia Global Partners LPNew Position+59K+$6.2M
Clearbridge Investments, LLCNew Position+61K+$6.0M
Lisanti Capital Growth, LLCNew Position+41K+$4.3M
Neuberger Berman Group LLCNew Position+45K+$4.0M
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCNew Position+48K+$4.0M
SUPERSTRING CAPITAL MANAGEMENT LPNew Position+25K+$2.7M
Avidity Partners Management LPNew Position+19K+$2.0M

PVLA — Institutions Reducing or Closing Positions

FundActionShares SoldValue Sold
BVF INC/ILDecreased-282K-$72.7B
PERCEPTIVE ADVISORS LLCDecreased-129K-$24.7B
Woodline Partners LPDecreased-45K-$21.6B
Point72 Asset Management, L.P.Decreased-240K-$19.9B
Nantahala Capital Management, LLCClosed Position-250K-$15.7B
GOLDMAN SACHS GROUP INCDecreased-138K-$14.8B
Samsara BioCapital, LLCDecreased-105K-$13.1B
FRED ALGER MANAGEMENT, LLCDecreased-37K-$11.7B
BALYASNY ASSET MANAGEMENT L.P.Decreased-58K-$10.4B
Blue Owl Capital Holdings LPDecreased-55K-$6.0B
RENAISSANCE TECHNOLOGIES LLCDecreased-67K-$5.6B
Ikarian Capital, LLCClosed Position-65K-$4.1B
Aberdeen Group plcClosed Position-51K-$3.2B
ROYCE & ASSOCIATES LPDecreased-19K-$3.1B
SECTORAL ASSET MANAGEMENT INCClosed Position-49K-$3.1B

Top Institutional Holders(Q4 2025)

#FundSharesValue% of PortfolioType
1SUVRETTA CAPITAL MANAGEMENT, LLC892,400$93.4M1.91%Share
2BVF INC/IL879,009$92.0M3.10%Share
3Frazier Life Sciences Management, L.P.722,400$75.6M2.03%Share
4First Light Asset Management, LLC709,141$74.2M5.67%Share
5VANGUARD GROUP INC495,710$51.9M0.00%Share
6STATE STREET CORP420,462$44.0M0.00%Share
7SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC389,420$40.8M0.85%Share
8JENNISON ASSOCIATES LLC387,483$40.6M0.02%Share
9FEDERATED HERMES, INC.368,038$38.0M0.06%Share
10Woodline Partners LP300,536$31.0M0.12%Share
11BlackRock, Inc.282,836$29.0M0.00%Share
12ALLIANCEBERNSTEIN L.P.269,027$28.0M0.01%Share
13PERCEPTIVE ADVISORS LLC266,287$27.9M0.50%Share
14FMR LLC231,671$24.0M0.00%Share
15BlackRock, Inc.224,558$23.0M0.00%Share
16Artisan Partners Limited Partnership211,553$22.0M0.03%Share
17MPM BioImpact LLC205,745$21.5M2.46%Share
18GEODE CAPITAL MANAGEMENT, LLC154,492$16.0M0.00%Share
19FRED ALGER MANAGEMENT, LLC150,026$15.0M0.06%Share
20MORGAN STANLEY120,510$12.0M0.00%Share
21BALYASNY ASSET MANAGEMENT L.P.108,880$11.0M0.01%Share
22Samsara BioCapital, LLC104,817$11.0M1.13%Share
23EVENTIDE ASSET MANAGEMENT, LLC101,748$10.6M0.17%Share
24Caption Management, LLC96,000$10.0M0.07%Call
25Caption Management, LLC95,300$10.0M0.07%Put
26Clio Asset Management LLC91,642$9.6M7.45%Share
27GOLDMAN SACHS GROUP INC92,112$9.0M0.00%Share
28NEXTBio Capital Management LP82,686$8.7M5.08%Share
29Point72 Asset Management, L.P.77,297$8.0M0.01%Share
30MORGAN STANLEY77,070$8.0M0.00%Share
31Siren, L.L.C.75,000$7.8M0.23%Share
32AWM Investment Company, Inc.69,416$7.3M0.70%Share
33Artia Global Partners LP59,200$6.2M0.88%Share
34Clearbridge Investments, LLC60,628$6.0M0.00%Share
35VANGUARD GROUP INC53,879$5.6M0.00%Share
36Invesco Ltd.50,550$5.3M0.00%Share
37NORTHERN TRUST CORP52,682$5.0M0.00%Share
38Lisanti Capital Growth, LLC41,470$4.3M1.03%Share
39Blue Owl Capital Holdings LP40,259$4.2M0.32%Share
40UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC47,650$4.0M0.00%Share
41ROYCE & ASSOCIATES LP30,010$3.1M0.03%Share
42Neuberger Berman Group LLC31,123$3.0M0.00%Share
43SUSQUEHANNA INTERNATIONAL GROUP, LLP38,200$3.0M0.00%Call
44UBS Group AG27,543$2.9M0.00%Share
45SUPERSTRING CAPITAL MANAGEMENT LP25,469$2.7M1.43%Share
46Avidity Partners Management LP19,300$2.0M0.58%Share
47BARCLAYS PLC25,136$2.0M0.00%Share
48BANK OF AMERICA CORP /DE/21,059$2.0M0.00%Share
49CHARLES SCHWAB INVESTMENT MANAGEMENT INC21,633$2.0M0.00%Share
50RENAISSANCE TECHNOLOGIES LLC22,530$2.0M0.00%Share

PVLA Institutional Ownership History

QuarterHoldersTotal ValueChange
Q4 2025139$986.4M+56
Q3 202583$497.6B+29
Q2 202554$115.9B+13
Q1 202541$143.4B+7
Q4 202434$48.4B+13
Q3 202421$5.4T+2
Q2 202419$2.8T—

Similar Stocks by Institutional Ownership

LLY

Eli Lilly and Company

JNJ

Johnson & Johnson

ABBV

AbbVie Inc.

NVS

Novartis AG

AZN

AstraZeneca PLC

MRK

Merck & Co., Inc.

UNH

UnitedHealth Group Incorporated

AMGN

Amgen Inc.

As of Q4 2025, 50 institutional investors hold PVLA (Palvella Therapeutics, Inc.). The largest holder is SUVRETTA CAPITAL MANAGEMENT, LLC with $93.4M in shares. This quarter, 15 institutions opened new positions and 4 closed their positions.

Frequently Asked Questions

How many hedge funds own PVLA?

As of Q4 2025, 50 institutional investors report holding PVLA (Palvella Therapeutics, Inc.) in their 13F filings.

Who is the largest institutional holder of PVLA?

The largest institutional holder of PVLA is SUVRETTA CAPITAL MANAGEMENT, LLC with $93.4M in shares.

Is institutional ownership of PVLA increasing or decreasing?

This quarter, 15 institutions opened new positions in PVLA and 4 closed their positions.